Published in Catheter Cardiovasc Interv on June 01, 2007
Clinical practice. Renal-artery stenosis. N Engl J Med (2009) 0.99
Renal artery stenosis-when to screen, what to stent? Curr Atheroscler Rep (2014) 0.92
Unilateral renal artery stenosis causes a chronic vascular inflammatory response in ApoE-/- mice. Trans Am Clin Climatol Assoc (2010) 0.88
Cardiovascular morbidity and mortality and renal artery stenosis. Prog Cardiovasc Dis (2009) 0.84
Statins and renovascular disease in the elderly: a population-based cohort study. Eur Heart J (2010) 0.82
Update on intervention versus medical therapy for atherosclerotic renal artery stenosis. J Vasc Surg (2015) 0.80
Survival in atherosclerotic renal artery stenosis: its all about renal function, or is it? Catheter Cardiovasc Interv (2007) 0.77
Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis. J Am Soc Hypertens (2015) 0.77
Is survival of patients with atherosclerotic renal artery stenosis affected by different predictors compared to other atherosclerosis manifestations? Catheter Cardiovasc Interv (2007) 0.75
Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease. J Vasc Interv Radiol (2016) 0.75
Renal artery stenosis: what we don't know won't hurt us. ...right? Catheter Cardiovasc Interv (2007) 0.75
Hemodynamic and neural responses to renal denervation of the nerve to the clipped kidney by cryoablation in two-kidney, one-clip hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.75
Endovascular versus medical therapy for atherosclerotic renovascular disease. Curr Atheroscler Rep (2014) 0.75
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 3.69
Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol (2005) 2.87
Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol (2012) 2.85
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv (2011) 2.57
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv (2010) 2.52
Meckel diverticulum: ten-year experience in adults. South Med J (2004) 2.32
Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry. Catheter Cardiovasc Interv (2010) 2.21
Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther (2012) 1.95
A readily available chiral Ag-based N-heterocyclic carbene complex for use in efficient and highly enantioselective Ru-catalyzed olefin metathesis and Cu-catalyzed allylic alkylation reactions. J Am Chem Soc (2005) 1.78
The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation (2006) 1.76
The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications. Catheter Cardiovasc Interv (2008) 1.75
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation (2012) 1.75
Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv (2007) 1.72
Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg (2013) 1.68
Vascular health in Kawasaki disease. J Am Coll Cardiol (2013) 1.67
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther (2006) 1.61
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke (2009) 1.58
Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv (2012) 1.56
The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol (2004) 1.55
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Catheter Cardiovasc Interv (2013) 1.52
Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol (2005) 1.51
Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med (2004) 1.47
Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther (2009) 1.47
Clinical outcomes following IVUS-guided stent deployment in a community hospital. J Invasive Cardiol (2004) 1.46
Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis. Catheter Cardiovasc Interv (2011) 1.44
Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J Clin Hypertens (Greenwich) (2014) 1.40
Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity. Obes Surg (2005) 1.40
Risk adjustment for case mix and the effect of surgeon volume on morbidity. JAMA Surg (2013) 1.40
Registry-Based Surveillance of Medical-Device Safety. N Engl J Med (2017) 1.39
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.36
Bidentate NHC-based chiral ligands for efficient Cu-catalyzed enantioselective allylic alkylations: structure and activity of an air-stable chiral Cu complex. J Am Chem Soc (2004) 1.32
Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol (2006) 1.31
Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J Vasc Surg (2007) 1.28
Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices. J Vasc Surg (2011) 1.27
An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg (2005) 1.23
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation (2011) 1.23
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med (2011) 1.19
Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv (2008) 1.13
Inferior vena cava filters. JACC Cardiovasc Interv (2013) 1.11
Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv (2008) 1.10
Subclavian artery stenting: factors influencing long-term outcome. Catheter Cardiovasc Interv (2004) 1.08
Angioplasty/stenting of the superior mesenteric artery and celiac trunk: early and late outcomes. J Endovasc Ther (2003) 1.08
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol (2005) 1.07
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol (2013) 1.07
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis (2011) 1.07
Predictors of percutaneous access failure requiring open femoral surgical conversion during endovascular aortic aneurysm repair. J Vasc Surg (2013) 1.02
Spontaneous blue finger syndrome: a benign process. Am J Med (2012) 0.99
Mesenteric/celiac duplex ultrasound interpretation criteria revisited. J Vasc Surg (2011) 0.99
Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv (2009) 0.99
The correlation of aortic neck length to early and late outcomes in endovascular aneurysm repair patients. J Vasc Surg (2009) 0.99
Noninvasive diagnostic strategies for peripheral arterial disease. Cleve Clin J Med (2006) 0.97
Shunting during carotid endarterectomy. J Vasc Surg (2011) 0.97
Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. J Endovasc Ther (2007) 0.96
Posterior wall capture and resultant common femoral occlusion complicating StarClose access closure. J Vasc Surg (2008) 0.95
The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995) (2014) 0.95
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv (2014) 0.94
Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study. JACC Cardiovasc Interv (2011) 0.94
Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv (2010) 0.94
Prospective randomized trial of routine versus selective shunting in carotid endarterectomy based on stump pressure. J Vasc Surg (2010) 0.93
The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril (2004) 0.93
StarClose vascular closure system (VCS) is safe and effective in patients who ambulate early following successful femoral artery access closure--results from the RISE clinical trial. Catheter Cardiovasc Interv (2011) 0.90
Vascular disorders in athletes. Vasc Med (2010) 0.90
SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv (2014) 0.89
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol (2013) 0.89
Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol (2004) 0.88
The effect of surgeon's specialty and volume on the perioperative outcome of carotid endarterectomy. J Vasc Surg (2013) 0.88
Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thickness. Atherosclerosis (2011) 0.88
Use of an amplatzer vascular plug for transcatheter embolization of a renal arteriovenous fistula. Vascular (2009) 0.88
Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option. Expert Rev Cardiovasc Ther (2011) 0.88
Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg (2011) 0.88
Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany. Catheter Cardiovasc Interv (2014) 0.88
Inferior vena cava filters: truth or dare? Circ Cardiovasc Interv (2013) 0.87
External iliac artery endofibrosis in an amateur runner: hemodynamic, angiographic, histopathological evaluation and percutaneous revascularization. Vasc Med (2007) 0.87
Percutaneous revascularization of occluded renal arteries in the setting of acute renal failure. Vasc Med (2009) 0.87
Postgraduate training in vascular medicine: proposed requirements and standards. Vasc Med (2003) 0.87
SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use. Catheter Cardiovasc Interv (2014) 0.87
Smoking in pregnancy in West Virginia: does cessation/reduction improve perinatal outcomes? Matern Child Health J (2012) 0.86